ADAMTS13 and thrombotic thrombocytopenic purpura: This study additionally reported that the presence of ADAMTS13 antibodies increased the likelihood of TTP recurrence (OR: 3.1, 95% CI: 1.4–7.3, p = 0.006) (33).